Lu Fu
Impact in
-
- Traditional Chinese Medicine Analysis
- Traditional Chinese Medicine Studies
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Traditional Chinese Medicine Analysis 4
- Co-authors
- Megan Susan Lord (11 shared papers)Lesheng Teng (1 shared paper)Ye Bi (1 shared paper)Erik De Clercq (2 shared papers)Boshi Huang (2 shared papers)Xinyong Liu (2 shared papers)John Michael Whitelock (6 shared papers)Cuicui Li (2 shared papers)
- Journals
- Protein Expression and Purification (2 papers)European Journal of Medicinal Chemistry (2 papers)Advanced Healthcare Materials (2 papers)Biomacromolecules (2 papers)RSC Advances (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Lu Fu
40 papers receiving 718 citations
Lu Fu's Hit Papers
Peers
Comparison fields: 5 of 92
- Complementary and alternative medicine 99
- Biomaterials 129
- Drug Discovery 2
- Computational Theory and Mathematics 94
- Health Informatics 11
Countries citing papers authored by Lu Fu
This map shows the geographic impact of Lu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Fu more than expected).
Fields of papers citing papers by Lu Fu
This network shows the impact of papers produced by Lu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Fu. The network helps show where Lu Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 123 | |
| 2 | 2015 | 88 | |
| 3 | ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine Hit paper breakdown → | 2023 | 86 |
| 4 | 2023 | 84 | |
| 5 | 2015 | 43 | |
| 6 | 2022 | 35 | |
| 7 | 2022 | 29 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 19 | |
| 10 | 2014 | 18 | |
| 11 | 2018 | 18 | |
| 12 | 2023 | 15 | |
| 13 | 2024 | 15 | |
| 14 | 2023 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2022 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2016 | 7 | |
| 20 | 2019 | 7 |
About Lu Fu
Lu Fu is a scholar working on Biomaterials, Complementary and alternative medicine, Surfaces, Coatings and Films, Cancer Research and Cell Biology, having authored 43 papers that have together received 738 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Phytochemistry and Biological Activities (4 papers), Traditional Chinese Medicine Analysis (4 papers), Proteoglycans and glycosaminoglycans research (3 papers), Sesquiterpenes and Asteraceae Studies (3 papers), Nanoparticles: synthesis and applications (3 papers), Computational Drug Discovery Methods (3 papers) and Polymer Surface Interaction Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (99 citations), Biomaterials (129 citations), Drug Discovery (2 citations), Computational Theory and Mathematics (94 citations) and Health Informatics (11 citations). Lu Fu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Megan Susan Lord, Lesheng Teng, Ye Bi, Erik De Clercq, Boshi Huang, Xinyong Liu, John Michael Whitelock, Cuicui Li, Christophe C. Pannecouque and Wen‐Ming Chen. Their work appears in journals such as Protein Expression and Purification, European Journal of Medicinal Chemistry, Advanced Healthcare Materials, Biomacromolecules and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.